{"id":46381,"date":"2022-07-20T16:02:05","date_gmt":"2022-07-20T14:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/"},"modified":"2022-07-20T16:02:05","modified_gmt":"2022-07-20T14:02:05","slug":"celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/","title":{"rendered":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Bolton brings over a decade of experience in representing and counseling life sciences companies in intellectual property, commercial, corporate governance, and employment matters<\/i>\n<\/p>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;Celmatix Inc., the leading women\u2019s health biotech focused uniquely on ovarian biology, today announced that Craig Bolton has been appointed as General Counsel. Bolton joins the Celmatix executive team after representing the biotech as outside counsel since 2019 and will play a critical role in supporting the company in ongoing therapeutic pipeline expansion and progress of their lead AMHR2 agonist program.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/5\/Celmatix_jpeg.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg\"><\/a><\/p>\n<p>\n\u201cAs we build on the continued success of our lead AMHR2 agonist program with additional innovative opportunities in women\u2019s health therapeutics, we are fortunate to have recruited an attorney with such breadth of experience,\u201d Dr. Piraye Yurttas Beim, Celmatix Founder and CEO commented. \u201cCraig has been an excellent partner to Celmatix as outside counsel, and we are thrilled to have him now join our executive team.\u201d\n<\/p>\n<p>\nThis announcement follows the company\u2019s recent appointment of women\u2019s health pioneer Dr. Bart CJM Fauser to the Chairmanship of its Scientific Advisory Board (SAB) and newly formed Clinical Trial Steering Committee.\n<\/p>\n<p>\n\u201cSince working with Celmatix, I have been deeply impressed by the strength of the team, their dedication to upholding high standards in scientific integrity, and their unwavering commitment to this underserved therapeutic area,\u201d said Mr. Bolton. \u201cIt is a great honor to now join as General Counsel and help Celmatix pursue its vital mission to improve the health and lives of women around the world.\u201d\n<\/p>\n<p>\nMr. Bolton is a seasoned litigator and counselor who has spent over a decade guiding both emerging and established biotech companies through complex commercial, intellectual property, and other business disputes. He has routinely advised boards of directors and special committees regarding litigation and corporate governance matters. Prior to joining Celmatix, Mr. Bolton was a partner at two nationally recognized law firms and an attorney at Wilson Sonsini Goodrich &amp; Rosati. Mr. Bolton graduated from New York University School of Law and was a law clerk to the Honorable William J. Martini of the United States District Court for the District of New Jersey.\n<\/p>\n<p>\n<b>About Celmatix<br \/>\n<br \/><\/b>Celmatix Inc. is a preclinical-stage women\u2019s health biotech focused uniquely on ovarian biology. With a lead \u201cpipeline-in-a-pill\u201d AMHR2 agonist program focused on ovarian senescence, and collaborations with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix\u2019s proprietary multi-omic ovarian health platform, the world\u2019s largest of its kind, is the foundation of the company\u2019s novel pipeline of first-in-class therapies. For more information, visit the company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.celmatix.com%2F&amp;esheet=52786351&amp;newsitemid=20220720005576&amp;lan=en-US&amp;anchor=www.celmatix.com&amp;index=1&amp;md5=50b9ad1feee4e755d469566f53f96454\" rel=\"nofollow noopener\" shape=\"rect\">www.celmatix.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJamie Kinder<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x6a;k&#x69;n&#100;&#x65;&#114;&#x40;&#109;&#x77;&#119;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#107;&#105;&#x6e;&#x64;&#101;&#114;&#x40;&#x6d;&#119;&#119;&#x2e;&#x63;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bolton brings over a decade of experience in representing and counseling life sciences companies in intellectual property, commercial, corporate governance, and employment matters NEW YORK&#8211;(BUSINESS WIRE)&#8211;Celmatix Inc., the leading women\u2019s health biotech focused uniquely on ovarian biology, today announced that Craig Bolton has been appointed as General Counsel. Bolton joins the Celmatix executive team after &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46381","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Bolton brings over a decade of experience in representing and counseling life sciences companies in intellectual property, commercial, corporate governance, and employment matters NEW YORK&#8211;(BUSINESS WIRE)&#8211;Celmatix Inc., the leading women\u2019s health biotech focused uniquely on ovarian biology, today announced that Craig Bolton has been appointed as General Counsel. Bolton joins the Celmatix executive team after ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-20T14:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy\",\"datePublished\":\"2022-07-20T14:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/\"},\"wordCount\":467,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005576\\\/en\\\/1518827\\\/21\\\/Celmatix_jpeg.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/\",\"name\":\"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005576\\\/en\\\/1518827\\\/21\\\/Celmatix_jpeg.jpg\",\"datePublished\":\"2022-07-20T14:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005576\\\/en\\\/1518827\\\/21\\\/Celmatix_jpeg.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005576\\\/en\\\/1518827\\\/21\\\/Celmatix_jpeg.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend","og_description":"Bolton brings over a decade of experience in representing and counseling life sciences companies in intellectual property, commercial, corporate governance, and employment matters NEW YORK&#8211;(BUSINESS WIRE)&#8211;Celmatix Inc., the leading women\u2019s health biotech focused uniquely on ovarian biology, today announced that Craig Bolton has been appointed as General Counsel. Bolton joins the Celmatix executive team after ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-20T14:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy","datePublished":"2022-07-20T14:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/"},"wordCount":467,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/","url":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/","name":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg","datePublished":"2022-07-20T14:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220720005576\/en\/1518827\/21\/Celmatix_jpeg.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/celmatix-appoints-seasoned-litigator-craig-bolton-as-general-counsel-to-support-pipeline-expansion-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel to Support Pipeline Expansion Strategy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46381"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46381\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}